RxSight Inc (RXST)
51.67
+0.57
(+1.12%)
USD |
NASDAQ |
Nov 04, 13:00
RxSight Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.1246 |
| March 31, 2023 | 0.278 |
| December 31, 2022 | 0.4468 |
| September 30, 2022 | 0.4171 |
| Date | Value |
|---|---|
| June 30, 2022 | 0.3626 |
| March 31, 2022 | 0.3239 |
| December 31, 2021 | 0.2876 |
| September 30, 2021 | 0.2627 |
| June 30, 2021 | -0.1261 |
| March 31, 2021 | -0.0976 |
| December 31, 2020 | -0.082 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.1261
Minimum
Jun 2021
0.4468
Maximum
Dec 2022
0.1465
Average
0.1246
Median
Jun 2023
Debt to Equity Ratio Benchmarks
| Tandem Diabetes Care Inc | 1.488 |
| Twist Bioscience Corp | 0.00 |
| Perspective Therapeutics Inc | -- |
| Xtant Medical Holdings Inc | 0.7481 |
| Catheter Precision Inc | 0.0454 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 305.50M |
| Total Liabilities (Quarterly) | 30.29M |
| Shareholders Equity (Quarterly) | 275.21M |
| Current Ratio | 14.33 |
| Net Debt Paydown Yield | 0.34% |